Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia
- PMID: 27509362
- PMCID: PMC5052100
- DOI: 10.1097/PCC.0000000000000915
Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia
Abstract
Objective: Enteral nutrition has been implicated as a risk factor for ventilator-associated pneumonia. We explored the prevalence of ventilator-associated pneumonia and its association with clinical and nutrition-related therapies in mechanically ventilated children.
Design: Prospective, multicenter, cohort study.
Setting: Fifty-nine PICU in 15 countries.
Patients: Children less than 18 years old, mechanically ventilated for more than 48 hours.
Interventions: None. Multivariable logistic regression to determine factors associated with ventilator-associated pneumonia.
Measurements and major results: Data are presented as median (interquartile range) or counts (%). We enrolled 1,245 subjects (45% women; 42% surgical), age 20 months (4-84 mo), and duration of mechanical ventilation 7 days (3-13 d). Culture-positive ventilator-associated pneumonia was diagnosed in 80 patients (6.4%); duration of mechanical ventilation for this subgroup was 17 days (8-39 d). Enteral nutrition was delivered in 985 patients (79%), initiated within 48 hours in 592 patients (60%), and via postpyloric route in 354 patients (36%). Acid-suppressive agents were used in 763 patients (61%). The duration of enteral nutrition (p = 0.21), route (gastric vs postpyloric) of delivery (p = 0.94), severity of illness (p = 0.17), and diagnostic category on admission (p = 0.31) were not associated with ventilator-associated pneumonia. After adjusting for enteral nutrition days, illness severity, and site, ventilator-associated pneumonia was significantly associated with mechanical ventilation more than 10 days (odds ratio, 3.7; 95% CI, 2.2-6.5; p < 0.001), PICU length of stay more than 10 days (odds ratio, 1.8; 95% CI, 1.1-3.1; p = 0.029), and the use of acid-suppressive medication (odds ratio, 2.0; 95% CI, 1.2-3.6; p = 0.011).
Conclusions: Ventilator-associated pneumonia was diagnosed in 6.5% of mechanically ventilated children in a heterogeneous multicenter cohort. We did not find a link between enteral nutrition duration or route of delivery and ventilator-associated pneumonia. In addition to duration of mechanical ventilation and length of PICU stay, the use of acid-suppressive therapy independently increased the likelihood of developing ventilator-associated pneumonia in this population. This association must be further explored in clinical trials.
Comment in
-
Another Piece to the Puzzle: "A Riddle Wrapped in a Mystery Inside an Enigma"-Winston Churchill.Pediatr Crit Care Med. 2016 Oct;17(10):1001-1003. doi: 10.1097/PCC.0000000000000928. Pediatr Crit Care Med. 2016. PMID: 27705986 No abstract available.
References
-
- Almuneef M, Memish ZA, Balkhy HH, et al. Ventilator-associated pneumonia in a pediatric intensive care unit in Saudi Arabia: a 30-month prospective surveillance. Infect Control Hosp Epidemiol. 2004;25(9):753–758. - PubMed
-
- Srinivasan R, Asselin J, Gildengorin G, et al. A prospective study of ventilator-associated pneumonia in children. Pediatrics. 2009;123(4):1108–1115. - PubMed
-
- Ibrahim EH, Mehringer L, Prentice D, et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr. 2002;26(3):174–181. - PubMed
-
- Casado RJ, de Mello MJ, de Aragao RC, et al. Incidence and risk factors for health care-associated pneumonia in a pediatric intensive care unit. Crit Care Med. 2011;39(8):1968–1973. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
